Characterization of prostaglandin E-2 receptors and their role in 24,25-(OH)(2)D-3-mediated effects on resting zone chondrocytes

Citation
F. Del Toro et al., Characterization of prostaglandin E-2 receptors and their role in 24,25-(OH)(2)D-3-mediated effects on resting zone chondrocytes, J CELL PHYS, 182(2), 2000, pp. 196-208
Citations number
47
Categorie Soggetti
Cell & Developmental Biology
Journal title
JOURNAL OF CELLULAR PHYSIOLOGY
ISSN journal
00219541 → ACNP
Volume
182
Issue
2
Year of publication
2000
Pages
196 - 208
Database
ISI
SICI code
0021-9541(200002)182:2<196:COPERA>2.0.ZU;2-9
Abstract
Resting zone chondrocyte differentiation is modulated by the vitamin D meab olite, 24,25-(OH)(2)D-3, via activation of protein kinase C (PKC). In previ ous studies, inhibition of prostaglandin production with indomethacin cause d an increase in PKC activity, suggesting that changes in prostaglandin lev els may mediate the 24,25-(OH)(2)D-3-dependent response and act as autocrin e or paracrine regulators of chandrocyte metabolism. Supporting this hypoth esis is the fact that resting zone cells respond directly to prostaglandin E-2 (PCE2). The aim of the present study was to identify which PGE, recepto r subtypes (EP) mediate the effects of PGE, on resting zone cells. Using pr imers specific for EP1-EP4, reverse transcription-polymerase chain reaction (RT-PCR) amplified EP1 and EP2 cDNA in a RT-dependent manner. A variant fo rm of the EP1 cDNA, EPIv, was also amplified in an RT-dependent manner. In parallel experiments, we used EP subtype-specific agonists to examine the r ole of EP receptors in 24,25-(OH),D,mediated cell proliferation and differe ntiation. 17-phenyl-trinor-PGE(2) (PTPGE(2)), an EP1 agonist, increased [H- 3]-thymidine incorporation in a dose-dependent manner and reversed the 24,2 5-(OH)(2)D-2-induced inhibition of [H-3]-thymidine incorporation. SC-19220, an EP1 antagonist, caused a further dose-dependent decrease in 24,25-(OH)( 2)D-2-induced inhibition of [H-3]-thymidine incorporation. PTPGE(2) also ca used a biphasic increase in [S-35]-sulfate incorporation and increased alka line phosphatase enzyme activity at high concentrations (10(-8) M). 24,25-( OH)(2)D-3-induced alkaline phosphatase activity was synergistically stimula ted in a dose-dependent manner by PTPGE(2). In contrast, 24,25-(OH)(2)D-3 i nduced PKC activity was inhibited in a dose-dependent manner by PTPGE, and SC-1 9220, the EP1 antagonist, elevated PKC activity at high concentrations (10-8 M). The EP2 agonist, misoprostol, only affected [S-35]-sulfate incor poration, but in a dose-dependent manner. The EP3 and EP4 agonists had no e ffect on cell response. These results suggest that the EP1 receptor subtype mediates some of the PGE(2)-induced cellular responses in resting zone cel ls that lead to both increased proliferation and differentiation. Because 2 4,25-(OH)(2)D-3 inhibits PGE(2) synthesis in these cells, EP1-mediated indu ction of proliferation is blocked, encouraging cellular maturation and acti vation of PKC activity. (C) 2000 Wiley-Liss, Inc.